Delay Future End Stage Nephropathy due to Diabetes

Completed

• Conditions: Diabetic Nephropathy; Metabolic and Endocrine - Diabetes; Renal and Urogenital - Other renal and urogenital disorders

• Registration Number: ACTRN12605000112662
• Lead Sponsor: John Collins

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-08-09
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 65

Inclusion Criteria

Maori and Pacific Islands patients with type 2 diabetes, with diabetic nephropathy (elevated 24 hour urine albumin of > 500mg /24hr and clinically defined using standard clinical symptoms/signs and exclusion of significant other causes for renal impairment) and impaired renal function (serum creatinine 0.10 to 0.3mmol/l) will be included in the study.

Exclusion Criteria

No exclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified